Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks. | Nat Aging | 2023 | 37217661 | PubTator, text mining | PubMed |
| Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review. | Front Oncol | 2023 | 37207160 | PubTator, text mining | PubMed |
| Hairy cell leukemia with isolated bone lesions. | Clin Case Rep | 2023 | 37207087 | PubTator, text mining | PubMed |
| Development, efficacy and side effects of antibody‑drug conjugates for cancer therapy (Review). | Mol Clin Oncol | 2023 | 37206431 | PubTator, text mining | PubMed |
| Polatuzumab-bendamustine-rituximab as bridge to CD19-directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax. | EJHaem | 2023 | 37206291 | PubTator, text mining | PubMed |
| IGH::CD274 (PD-L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication. | EJHaem | 2023 | 37206267 | PubTator, text mining | PubMed |
| Classification of tuberculosis-related programmed cell death-related patient subgroups and associated immune cell profiling. | Front Immunol | 2023 | 37205113 | PubTator, text mining | PubMed |
| Inactivating Activities and Mechanism of Imidazo[1,2-c]pyrimidin-5(6H)-one Nucleoside Derivatives Incorporating a Sulfonamide Scaffold. | J Agric Food Chem | 2023 | 37204296 | PubTator, text mining | PubMed |
Outcomes of polatuzumab vedotin-containing regimens in real-world setting of relapsed and or refractory diffuse large B-cell lymphoma patients: a matched-control analysis from the Thai Lymphoma Study Group (TLSG). | Ann Hematol | 2023 | 37202499 | PubTator, text mining | PubMed |
| Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts. | Cancers (Basel) | 2023 | 37190213 | PubTator, text mining | PubMed |
| Plasma Cytokeratin-18 Fragment Level Reflects the Metabolic Phenotype in Obesity. | Biomolecules | 2023 | 37189422 | PubTator, text mining | PubMed |
| Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing. | Front Immunol | 2023 | 37187731 | PubTator, text mining | PubMed |
| Generative pretraining from large-scale transcriptomes for single-cell deciphering. | iScience | 2023 | 37187700 | PubTator, text mining | PubMed |
| The Role of Intravesicular Proteins and the Protein Corona of Extracellular Vesicles in the Development of Drug-Induced Polyneuropathy. | Curr Issues Mol Biol | 2023 | 37185740 | PubTator, text mining | PubMed |
| Identification of an anergic BND cell-derived activated B cell population (BND2) in young-onset type 1 diabetes patients. | J Exp Med | 2023 | 37184563 | PubTator, text mining | PubMed |
| BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through PAX5. | Blood Adv | 2023 | 37184294 | PubTator, text mining | PubMed |
| Orbital Infiltration in a Patient with Waldenström Macroglobulinemia: Need for Multidisciplinary Approach and Comparison with the Literature. | Mediterr J Hematol Infect Dis | 2023 | 37180207 | PubTator, text mining | PubMed |
| A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells. | Front Immunol | 2023 | 37180149 | PubTator, text mining | PubMed |
| B-Cell Receptor Signaling Is Thought to Be a Bridge between Primary Sjogren Syndrome and Diffuse Large B-Cell Lymphoma. | Int J Mol Sci | 2023 | 37176092 | PubTator, text mining | PubMed |
| Sc@B28-, Ti@B28, V@B28+, and V@B292-: Spherically Aromatic Endohedral Seashell-like Metallo-Borospherenes. | Molecules | 2023 | 37175301 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=34